Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noninvasive Markers of Functional Nausea in Children
NCT03593811Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2018
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial (5 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Percentage of Normal Slow Waves at 6 months. Started Aug 2018; status: completed.
Beyond the preview
Go deeper on NCT03593811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593811.